![Laurent Humeau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 31 699 $ au 31/07/2026
Laurent M.
Humeau is Director at Geneos Therapeutics, Inc. since 2022.
Dr. Humeau is Chief Scientific Officer at Inovio Pharmaceuticals, Inc. since 2019.
Former positions include Senior Director-Translational Research at Precigen, Inc., Senior Director-Translational Research at Intrexon Corp., and Chief Scientific Officer & Vice President-Research at VIRxSYS Corp.
Education includes undergraduate and graduate degrees from Université Pierre et Marie Curie and a doctorate from Université Paris Diderot-Paris 7.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 46 823 ( 0,06% ) | 31 699 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 18/02/2014 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Directeur/Membre du Conseil | 12/10/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
